Evaluation of the risk factors for febrile neutropenia associated with hematological malignancy

Journal of Infection and Chemotherapy

Volumn 15, Issue 3, 2009, Pages 174-179

  Nakagawa, Yasunori ^a   Suzuki, Kenshi ^a   Masaoka, Toru ^b  

^a JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Febrile neutropenia; Hematologic malignancy; Risk factor

Indexed keywords

ALBUMIN; ANTIFUNGAL AGENT; C REACTIVE PROTEIN; CREATINE; FLUCONAZOLE; ITRACONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CANCER PATIENT; CLINICAL EVALUATION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; FEBRILE NEUTROPENIA; FEMALE; HEMATOLOGIC DISEASE; HEMATOLOGIC MALIGNANCY; HIGH RISK PATIENT; HUMAN; INFECTION RISK; LEUKOCYTE COUNT; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; RETROSPECTIVE STUDY; RISK ASSESSMENT;

EID: 67651204770     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-009-0683-y     Document Type: Article

References (3)

1. W.T. Hughes D. Armstrong G.P. Bodey R. Feld G.L. Mandell J.D. Meyers 1990 From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with cancer J Infect Dis 161 381 396
2. J. Klastersky M. Paesmans E.B. Rubenstein M. Boyer L. Elting R. Feld 2002 The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients J Clin Oncol 18 3038 3051 (Pubitemid 30644129)
3. T. Masaoka 2004 Evidence-based recommendations for antimicrobial use in febrile neutropenia in Japan: executive summary Clin Infect Dis 39 Suppl1 S49 S52